Companies: 10,795·Total market cap: $144.5T
Geron Corporation

Geron Corporation

GERNNASDAQHealthcare● Active
$1.17
$-0.01(-0.43%)
Market Cap$747371935
P/E Ratio—
52W High$2.01
52W Low$1.04
SEC Filings

Geron Corporation (GERN) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0000886744 · GERN · NASDAQ · as of Jun 8, 2026

Filing snapshot

1,000+
Total Filings
8-K
Latest Form
2026-05-27
Most Recent
1996
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0000886744 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-02
Fiscal Year End
Mar 2, 2026
Accession No.
0000886744-26-000008
Primary Document
gern-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0000886744 · Accession 0000886744-26-000008

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-06
View 10-Q on SEC
8-KCurrent Report
8-K
2026-05-27Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-05-27
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-08
View
10-QQuarterly Report
10-Q
2026-05-06
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-14
View
ARSARS
ARS
2026-04-07
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-07
View
DEF 14AProxy Statement
DEF 14A
2026-04-07
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-03-26
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-26
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-26
View
8-KCurrent Report
8-K
2026-03-26
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-03-03
View
S-3ASRS-3ASR
S-3ASR
2026-03-02
View
10-KAnnual Report
10-K
2026-03-02
View
Showing 1–15 of 549 filingsForm 4 / 144 hidden· 1000 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0000886744  |  Exchange: NASDAQ · Healthcare

Geron Corporation (NASDAQ: GERN) has submitted 1,000+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1996. As a Healthcare sector company with CIK 0000886744, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Geron Corporation's most comprehensive regulatory disclosure. The most recent Geron Corporation 10-K was filed on 2026-03-02 for fiscal year ending 2026. Historical GERN 10-K annual reports are available from 2009 through 2026.

Investors researching Geron Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
DAWN SEC Filings →TYRA SEC Filings →VIR SEC Filings →AVBP SEC Filings →SVRA SEC Filings →REPL SEC Filings →ARVN SEC Filings →VALN SEC Filings →
→ GERN Financials→ GERN Earnings→ GERN Insider Trades

Frequently Asked Questions

GERN SEC Filings · 8 questions

Geron Corporation (GERN) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,000+ filings and access original documents at no cost. Geron Corporation's CIK is 0000886744.

GERN SEC filingsGeron Corporation SEC documentsfind GERN 10-K